Concurrent mucous membrane pemphigoid and membranous glomerulonephritis in a patient with autoantibodies targeting the 1080 region of collagen XVII-Reference-Cited by-同舟云学术

Concurrent mucous membrane pemphigoid and membranous glomerulonephritis in a patient with autoantibodies targeting the 1080 region of collagen XVII

Published:2019-07-15 Issue:4 Volume:181 Page:835-836
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Stump M.¹^ORCID,Messingham K.N.¹,Fairley J.A.¹

Affiliation:

1. Department of Dermatology Roy J. and Lucille A. Carver College of Medicine, University of Iowa, and Veterans Administration Medical Center Iowa City Iowa U.S.A.

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.17923

Reference8 articles.

1. A case of subepidermal blistering disease with autoantibodies to multiple laminin subunits who developed later autoantibodies to alpha‐5 chain of type IV collagen associated with membranous glomerulonephropathy;Sueki H;Acta Derm Venereol,2015

2. Bullous Pemphigoid With a Dual Pattern of Glomerular Immune Complex Disease

3. Missing the target: Characterization of bullous pemphigoid patients who are negative using the BP180 enzyme-linked immunosorbant assay

4. Phospholipase A2 receptor staining is absent in many kidney biopsies with early-stage membranous glomerulonephritis

5. Transmembrane collagen XVII is a novel component of the glomerular filtration barrier

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pemphigus vulgaris and focal segmental glomerulosclerosis (FSGS): First reported case and a review of the literature;Clinical Case Reports;2023-07

2. Use of rituximab in the treatment of mucous membrane pemphigoid: An analytic review;Autoimmunity Reviews;2022-08

3. A Case of Severe and Refractory Membranous Nephropathy Associated to Mucous Membrane Pemphigoid;Case Reports in Nephrology;2021-05-11

4. Update on IgG4-mediated autoimmune diseases: New insights and new family members;Autoimmunity Reviews;2020-10

5. Targeting interleukin 4 receptor α: A new approach to the treatment of cutaneous autoimmune bullous diseases?;Dermatologic Therapy;2020-01